Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

527 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Subtyping of Group 3/4 medulloblastoma as a potential prognostic biomarker among patients treated with reduced dose of craniospinal irradiation: a Japanese Pediatric Molecular Neuro-Oncology Group study.
Fukuoka K, Kurihara J, Shofuda T, Kagawa N, Yamasaki K, Ando R, Ishida J, Kanamori M, Kawamura A, Park YS, Kiyotani C, Akai T, Keino D, Miyairi Y, Sasaki A, Hirato J, Inoue T, Nakazawa A, Koh K, Nishikawa R, Date I, Nagane M, Ichimura K, Kanemura Y. Fukuoka K, et al. Among authors: nakazawa a. Acta Neuropathol Commun. 2023 Sep 25;11(1):153. doi: 10.1186/s40478-023-01652-4. Acta Neuropathol Commun. 2023. PMID: 37749662 Free PMC article.
Optimal timing of liver transplantation for liver cirrhosis caused by sclerosing cholangitis in a patient with Langerhans cell histiocytosis: a case report.
Watakabe M, Fukuoka K, Ihara Y, Hara T, Kudo K, Tamura M, Ichimura K, Tanami Y, Kawashima H, Iwama I, Nakazawa A, Mizuta K, Koh K. Watakabe M, et al. Among authors: nakazawa a. Int J Hematol. 2023 May;117(5):759-764. doi: 10.1007/s12185-022-03500-y. Epub 2022 Dec 5. Int J Hematol. 2023. PMID: 36469185
Intensification of treatment with vinca alkaloid does not improve outcomes in pediatric patients with Langerhans cell histiocytosis: results from the JPLSG LCH-12 study.
Morimoto A, Shioda Y, Kudo K, Kanegane H, Imamura T, Koh K, Kosaka Y, Yuza Y, Nakazawa A, Saito AM, Watanabe T, Nakazawa Y. Morimoto A, et al. Among authors: nakazawa y, nakazawa a. Int J Hematol. 2023 Jul;118(1):107-118. doi: 10.1007/s12185-023-03568-0. Epub 2023 Mar 4. Int J Hematol. 2023. PMID: 36871086 Clinical Trial.
An infantile pineal embryonal tumor showing pathological features of a CNS ganglioneuroblastoma and the methylation profiling of an atypical teratoid/rhabdoid tumor and SMARCA4 mutation.
Fukuoka K, Nakazawa A, Hirato J, Nobusawa S, Itabashi T, Arakawa Y, Mori M, Matsushita Y, Honda S, Tanami Y, Ichimura K, Kurihara J, Koh K. Fukuoka K, et al. Among authors: nakazawa a. J Neuropathol Exp Neurol. 2023 Jun 20;82(7):664-667. doi: 10.1093/jnen/nlad033. J Neuropathol Exp Neurol. 2023. PMID: 37086056 No abstract available.
Early chemotherapeutic intervention to avoid thyroidectomy in pediatric Langerhans cell histiocytosis with thyroid involvement accompanying tracheal stenosis: a report of two cases.
Aoyama S, Fukuoka K, Kubota H, Narita K, Kudo K, Mitani Y, Oshima K, Mori M, Arakawa Y, Ichimura K, Terui K, Tanami Y, Kawashima H, Nakazawa A, Niitsu T, Takahashi Y, Koh K. Aoyama S, et al. Among authors: nakazawa a. Int J Hematol. 2024 Jan;119(1):99-103. doi: 10.1007/s12185-023-03662-3. Epub 2023 Sep 23. Int J Hematol. 2024. PMID: 37740816
A nationwide phase II study of delayed local treatment for children with high-risk neuroblastoma: The Japan Children's Cancer Group Neuroblastoma Committee Trial JN-H-11.
Yoneda A, Shichino H, Hishiki T, Matsumoto K, Ohira M, Kamijo T, Kuroda T, Soejima T, Nakazawa A, Takimoto T, Yokota I, Teramukai S, Takahashi H, Fukushima T, Hara J, Kaneko M, Ikeda H, Tajiri T, Mugishima H, Nakagawara A. Yoneda A, et al. Among authors: nakazawa a. Pediatr Blood Cancer. 2024 Jun;71(6):e30976. doi: 10.1002/pbc.30976. Epub 2024 Apr 5. Pediatr Blood Cancer. 2024. PMID: 38577760 Clinical Trial.
Clinical symptoms, biochemistry, and liver histology during the native liver period of progressive familial intrahepatic cholestasis type 2.
Kondou H, Nakano S, Mizuno T, Bessho K, Hasegawa Y, Nakazawa A, Tanikawa K, Azuma Y, Okamoto T, Inui A, Imagawa K, Kasahara M, Zen Y, Suzuki M, Hayashi H. Kondou H, et al. Among authors: nakazawa a. Orphanet J Rare Dis. 2024 Feb 10;19(1):57. doi: 10.1186/s13023-024-03080-6. Orphanet J Rare Dis. 2024. PMID: 38341604 Free PMC article.
527 results